Annual CAPEX
$6.15 M
-$29.41 M-82.70%
December 31, 2023
Summary
- As of February 12, 2025, FATE annual capital expenditures is $6.15 million, with the most recent change of -$29.41 million (-82.70%) on December 31, 2023.
- During the last 3 years, FATE annual CAPEX has risen by +$1.22 million (+24.76%).
- FATE annual CAPEX is now -87.86% below its all-time high of $50.70 million, reached on December 31, 2021.
Performance
FATE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$495.00 K
+$444.00 K+870.59%
September 30, 2024
Summary
- As of February 12, 2025, FATE quarterly capital expenditures is $495.00 thousand, with the most recent change of +$444.00 thousand (+870.59%) on September 30, 2024.
- Over the past year, FATE quarterly CAPEX has dropped by -$70.00 thousand (-12.39%).
- FATE quarterly CAPEX is now -97.31% below its all-time high of $18.37 million, reached on December 31, 2021.
Performance
FATE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$813.00 K
-$70.00 K-7.93%
September 30, 2024
Summary
- As of February 12, 2025, FATE TTM capital expenditures is $813.00 thousand, with the most recent change of -$70.00 thousand (-7.93%) on September 30, 2024.
- Over the past year, FATE TTM CAPEX has dropped by -$11.84 million (-93.57%).
- FATE TTM CAPEX is now -98.57% below its all-time high of $56.81 million, reached on March 31, 2022.
Performance
FATE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
FATE CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -82.7% | -12.4% | -93.6% |
| 3 y3 years | +24.8% | -84.6% | -97.2% |
| 5 y5 years | +167.2% | -53.7% | -87.9% |
FATE CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.9% | at low | -97.3% | +870.6% | -98.6% | at low |
| 5 y | 5-year | -87.9% | +24.8% | -97.3% | +870.6% | -98.6% | at low |
| alltime | all time | -87.9% | >+9999.0% | -97.3% | +6971.4% | -98.6% | >+9999.0% |
Fate Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $495.00 K(+870.6%) | $813.00 K(-7.9%) |
| Jun 2024 | - | $51.00 K(-40.7%) | $883.00 K(-70.9%) |
| Mar 2024 | - | $86.00 K(-52.5%) | $3.03 M(-50.7%) |
| Dec 2023 | $6.15 M(-82.7%) | $181.00 K(-68.0%) | $6.15 M(-51.4%) |
| Sep 2023 | - | $565.00 K(-74.3%) | $12.65 M(-39.1%) |
| Jun 2023 | - | $2.20 M(-31.5%) | $20.76 M(-27.6%) |
| Mar 2023 | - | $3.21 M(-52.0%) | $28.69 M(-19.3%) |
| Dec 2022 | $35.57 M(-29.9%) | $6.68 M(-23.0%) | $35.57 M(-24.7%) |
| Sep 2022 | - | $8.68 M(-14.3%) | $47.26 M(-11.4%) |
| Jun 2022 | - | $10.13 M(+0.4%) | $53.32 M(-6.1%) |
| Mar 2022 | - | $10.08 M(-45.1%) | $56.81 M(+12.0%) |
| Dec 2021 | $50.70 M(+928.1%) | $18.37 M(+24.7%) | $50.70 M(+46.5%) |
| Sep 2021 | - | $14.73 M(+8.2%) | $34.61 M(+66.2%) |
| Jun 2021 | - | $13.62 M(+242.1%) | $20.83 M(+165.5%) |
| Mar 2021 | - | $3.98 M(+75.2%) | $7.84 M(+59.0%) |
| Dec 2020 | $4.93 M(-33.3%) | $2.27 M(+138.2%) | $4.93 M(-6.1%) |
| Sep 2020 | - | $954.00 K(+50.0%) | $5.25 M(-5.6%) |
| Jun 2020 | - | $636.00 K(-40.6%) | $5.56 M(-17.2%) |
| Mar 2020 | - | $1.07 M(-58.7%) | $6.72 M(-9.1%) |
| Dec 2019 | $7.39 M(+221.1%) | $2.59 M(+104.9%) | $7.39 M(+24.9%) |
| Sep 2019 | - | $1.26 M(-29.6%) | $5.92 M(+10.0%) |
| Jun 2019 | - | $1.79 M(+2.8%) | $5.38 M(+39.2%) |
| Mar 2019 | - | $1.75 M(+56.3%) | $3.87 M(+67.8%) |
| Dec 2018 | $2.30 M | $1.12 M(+54.3%) | $2.30 M(+16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $724.00 K(+160.4%) | $1.98 M(+22.3%) |
| Jun 2018 | - | $278.00 K(+51.1%) | $1.62 M(-7.6%) |
| Mar 2018 | - | $184.00 K(-76.9%) | $1.75 M(+1.7%) |
| Dec 2017 | $1.73 M(+277.5%) | $797.00 K(+120.2%) | $1.73 M(+78.2%) |
| Sep 2017 | - | $362.00 K(-11.9%) | $968.00 K(+51.5%) |
| Jun 2017 | - | $411.00 K(+165.2%) | $639.00 K(+47.2%) |
| Mar 2017 | - | $155.00 K(+287.5%) | $434.00 K(-5.0%) |
| Dec 2016 | $457.00 K(-69.5%) | $40.00 K(+21.2%) | $457.00 K(-23.2%) |
| Sep 2016 | - | $33.00 K(-84.0%) | $595.00 K(-51.1%) |
| Jun 2016 | - | $206.00 K(+15.7%) | $1.22 M(-0.6%) |
| Mar 2016 | - | $178.00 K(0.0%) | $1.22 M(-18.3%) |
| Dec 2015 | $1.50 M(+69.8%) | $178.00 K(-72.8%) | $1.50 M(-5.8%) |
| Sep 2015 | - | $655.00 K(+207.5%) | $1.59 M(+41.7%) |
| Jun 2015 | - | $213.00 K(-52.9%) | $1.12 M(+20.0%) |
| Mar 2015 | - | $452.00 K(+66.8%) | $936.00 K(+6.1%) |
| Dec 2014 | $882.00 K(+261.5%) | $271.00 K(+44.9%) | $882.00 K(+15.9%) |
| Sep 2014 | - | $187.00 K(+619.2%) | $761.00 K(+27.5%) |
| Jun 2014 | - | $26.00 K(-93.5%) | $597.00 K(-6.0%) |
| Mar 2014 | - | $398.00 K(+165.3%) | $635.00 K(+160.2%) |
| Dec 2013 | $244.00 K(-65.6%) | $150.00 K(+552.2%) | $244.00 K(+159.6%) |
| Sep 2013 | - | $23.00 K(-64.1%) | $94.00 K(+32.4%) |
| Jun 2013 | - | $64.00 K(+814.3%) | $71.00 K(+914.3%) |
| Mar 2013 | - | $7000.00 | $7000.00 |
| Dec 2012 | $709.00 K(>+9900.0%) | - | - |
| Dec 2011 | $2000.00 | - | - |
FAQ
- What is Fate Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Fate Therapeutics?
- What is Fate Therapeutics annual CAPEX year-on-year change?
- What is Fate Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Fate Therapeutics?
- What is Fate Therapeutics quarterly CAPEX year-on-year change?
- What is Fate Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Fate Therapeutics?
- What is Fate Therapeutics TTM CAPEX year-on-year change?
What is Fate Therapeutics annual capital expenditures?
The current annual CAPEX of FATE is $6.15 M
What is the all time high annual CAPEX for Fate Therapeutics?
Fate Therapeutics all-time high annual capital expenditures is $50.70 M
What is Fate Therapeutics annual CAPEX year-on-year change?
Over the past year, FATE annual capital expenditures has changed by -$29.41 M (-82.70%)
What is Fate Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of FATE is $495.00 K
What is the all time high quarterly CAPEX for Fate Therapeutics?
Fate Therapeutics all-time high quarterly capital expenditures is $18.37 M
What is Fate Therapeutics quarterly CAPEX year-on-year change?
Over the past year, FATE quarterly capital expenditures has changed by -$70.00 K (-12.39%)
What is Fate Therapeutics TTM capital expenditures?
The current TTM CAPEX of FATE is $813.00 K
What is the all time high TTM CAPEX for Fate Therapeutics?
Fate Therapeutics all-time high TTM capital expenditures is $56.81 M
What is Fate Therapeutics TTM CAPEX year-on-year change?
Over the past year, FATE TTM capital expenditures has changed by -$11.84 M (-93.57%)